Replimune (REPL) Property, Plant & Equipment (Net) Growth (1y) (2019 - 2025)
Replimune (REPL) Property, Plant & Equipment (Net) Growth (1y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-13.32% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
17.12% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
-14.18% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
24.11% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Replimune |
780.01 Mn |
510.88 Mn |
- |
1.70% |
| Date | Value |
|---|
| Dec 31, 2025 |
1.70% |
| Sep 30, 2025 |
16.84% |
| Jun 30, 2025 |
28.73% |
| Mar 31, 2025 |
31.06% |
| Dec 31, 2024 |
43.73% |
| Sep 30, 2024 |
49.09% |
| Jun 30, 2024 |
49.72% |
| Mar 31, 2024 |
40.17% |
| Dec 31, 2023 |
23.36% |
| Sep 30, 2023 |
6.76% |
| Jun 30, 2023 |
-7.87% |
| Mar 31, 2023 |
-5.72% |
| Dec 31, 2022 |
3.60% |
| Sep 30, 2022 |
10.20% |
| Jun 30, 2022 |
15.20% |
| Mar 31, 2022 |
6.60% |
| Dec 31, 2021 |
3.43% |
| Sep 30, 2021 |
0.17% |
| Jun 30, 2021 |
-2.46% |
| Mar 31, 2021 |
8.48% |
